Nuo Therapeutics Inc. Insider Trading

AURX

⊜ Compare

Last 12 months

Insiders bought 10K and sold 300K on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan.

Net open-market

−290K

1 buy · 1 sale

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

1 / 1

executives and directors

Last open-market buy

Aug 2026

Aug 28, 2026

Get an email when AURX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 27 – 28	David Emerson Jorden Ceo/cfo	Bought 2 parts	8,773	$1.09 average	10K	0.4%	Form 4
Nov 28, 2025	David Emerson Jorden Ceo/cfo	SoldNo plan	200,000	$1.50	300K	9.3%	Form 4
Jul 30, 2025	Charles E Sheedy Large holder	Bought	133,333	$1.50	200K	1.2%	Form 4

Aug 27 – 28
David Emerson Jorden
Ceo/cfo · bought 8,773 at avg $1.09
10K
0.4% of stake
Nov 28, 2025No plan
David Emerson Jorden
Ceo/cfo · sold 200,000 at $1.50
300K
9.3% of stake
Jul 30, 2025
Charles E Sheedy
Large holder · bought 133,333 at $1.50
200K
1.2% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch AURX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with AURX

CompareIntrinsic value

TNONTenon Medical Inc.

$1.91+1.06%40

LUCDLucid Diagnostics Inc.

$0.44+8.80%44

INBSIntelligent Bio Solutions Inc.

$1.75-1.13%40

PSTVPlus Therapeutics Inc

No recent price28

PMIPicard Medical, Inc.

$7.19-7.58%30

ECIAEncision Inc.

$0.03+160.87%14

ICCMIceCure Medical Ltd.

$0.79+2.54%43

USAQQHSLab Inc.

$0.32-15.00%49

Spot a number that looks wrong? Check it in AURX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AURX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.